Personalized medicine: Innovative online journal lea...( The recent surge of DNA sequence inf...)

The recent surge of DNA sequence information resulting from deciphering the human genetic code has acted as a catalyst for innovative technological developments that have been vital in the identification of genes associated with disease pathologies. This has allowed for the development of novel genetic therapies to treat a wide range of inherited disorders.

The new genomic era heralds earlier diagnoses, greatly improved prevention and treatment of diseases and enhanced avoidance of side effects from drugs.

Now, the latest information and findings that have an impact on the understanding and management of human health and disease will be available online to physicians around the globe with the launch of BioMed Central's premier medical journal Genome Medicine.

Today, Genome Medicine, an online peer-reviewed open access research journal will be launched at a special event at the 58th annual meeting of the American Society of Human Genetics (ASHG), in Philadelphia.

The launch issue is sponsored by Agilent, the electronic and bio-analytical measurement company. In addition to publishing high-quality research, Genome Medicine serves the international research community as a forum for the discussion and critical review of information about all areas of medicine informed by genomic research.

Genome Medicine will focus on the following areas:

• Significant advances in the understanding of the genetics, genomics, and epigenetics of disease
• Computational and systems approaches, including proteomics, metabolomics and transcriptomics, to the understanding and management of disease
• Genomic epidemiology and public health genomics
• The application of genomic and post-genomic technologies to clinical practice, with special emphasis on diagnostics and therapeutics
• Personalized medicine
• Ethical, social and legal issues relating to genomic medi
  '/>"/>